$UAMY

Why United States Antimony Stock Was a big Winner on Wednesday

United States Antimony (UAMY) shares rose about 8% on Wednesday, according to market data, after a board member purchase. In a regulatory filing, director Jon Marinelli bought 12,500 shares at $7.45 each. Marinelli was appointed to the board in late November, expanding it to seven members.

Original reporting
Published Jun 18, 2026, 1:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 1:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why United States Antimony Stock Was a big Winner on Wednesday — source image
Decision brief

The 30-second read

$UAMYBullishLow
01

Why it matters

The disclosed director purchase is framed as boosting investor morale and coinciding with an ~8% Wednesday gain, but the piece does not introduce new financial results, contracts, or regulatory outcomes.

02

Market read

Traders may treat the insider buy as a short-term sentiment catalyst, but the lack of fundamental updates limits conviction for sustained repricing.

03

What to watch

The article notes negative gross margin and “rich” valuation, suggesting downside risk if the insider-driven momentum doesn’t translate into fundamentals.

Relevance 6/10Novelty 4/10Timing: Wednesday session / same-day price move tied to the insider purchase disclosure

Background

U.S. Antimony is described as the sole North American antimony producer with antimony used in semiconductor-related applications.

Company-level read

Ticker impact

$UAMYBullishMedium confidence
Context

U.S. Antimony shares jumped ~8% after a board member bought 12,500 shares at $7.45 per share in a disclosed transaction.

Expected impact

Near-term: modest support to the stock; follow-through depends on whether volume/price action persists beyond the insider headline.

Evidence & confidence

The article cites a specific Form 4-style insider purchase (12,500 shares at $7.45) and links it to the same-day rally, but offers no new operational or financial guidance.

Market effects

Highlights investor focus on antimony supply constraints tied to semiconductor demand, but provides no new sector data.

Limited; single small-cap US-listed issuer move.

Low; no new global supply, policy, or demand information beyond general semiconductor linkage.

Counterpoint

Insider buys can be routine or opportunistic; without changes to production, contracts, or guidance, the rally may fade.

Key entities

  • United States Antimony

    Subject of the article; stock rose ~8% on the day of a disclosed director share purchase.

  • Jon Marinelli

    Board director who bought 12,500 shares at $7.45 per share; appointed in late November of the prior year.

Related articles

$UAMYMed

Why Shares of United States Antimony Are Soaring This Week

United States Antimony (UAMY) shares rose about 12.2% from last Friday to 1:21 p.m. after the company reported completing initial Q2 2026 shipments under a $245M Defense Logistics Agency supply contract. It delivered ~82,000 pounds of antimony ingots, generating ~$2.6M, and is awaiting inspections for two more shipments. UAMY has received $57.3M in orders since contract start.

$UAMYMed

United States Antimony Corp.: United States Antimony Corporation Provides Update on Antimony Shipments to the DoW

United States Antimony Corp. (NYSE:UAMY) said it delivered the first shipments in Q2 2026 under a $245 million Defense Logistics Agency (DLA) supply contract. It shipped ~82,000 pounds of antimony metal ingots, generating about $2.6 million in June invoices. Total DLA orders since contract start are $57.3 million; two more shipments await inspection and authorization.

$USASMedAI 9/10

Americas extends hot streak with Cosalá hits

Americas Gold and Silver said new Cosalá infill drill results, reported after an Oct. 31 cutoff, returned grades up to 5x above its resource model at San Rafael Upper and 120 zones and are feeding mine planning for the second half. Examples include SR568 (14m of 599.8 g/t silver, 0.83% Cu) and 120-25-G95 (45m of 342.9 g/t silver, 0.85% Cu). The company also budgeted ~$20m for a 64,000m drill program.

$UAMYMedAI 8/10

I'm Thinking About Pulling the Trigger on This Producer of a Mineral Deemed "Critical" to the U.S.

The article says U.S. demand for antimony—classified by the U.S. as a critical mineral—has driven investor interest as the U.S. imports about 90% of its needs, while China is the largest producer. United States Antimony (UAMY) reported weaker first-quarter results, with revenue declining and a loss. It secured a federal sole-source contract worth up to $245 million, with a $10 million initial order, and had $39 million revenue in 2025.

$UAMYMedAI 8/10

I'm Thinking About Pulling the Trigger on This Producer of a Mineral Deemed "Critical" to the U.S.

The article says U.S. Antimony (NYSE: UAMY) is gaining investor attention as the U.S. seeks alternatives to China for “critical” minerals. It cites antimony’s military and semiconductor uses and notes the company’s first-quarter results showed revenue decline and a loss. U.S. Antimony received a sole-source federal contract worth up to $245 million, with $10 million initially ordered, and reported $39 million revenue in 2025.